New trends and approaches in venture capital financing, 4th edition - Lessons for Canada's Life Sciences Industry

New trends and approaches in venture capital financing, 4th edition - Lessons for Canada's Life Sciences Industry

Par Montréal InVivo

Date et heure

lun. 3 juin 2019 13:00 - 14:15 EDT

Endroit

Le Méridien Philadelphia

1421 Arch Street Philadelphia, PA 19102

Description

New trends and approaches in venture capital financing, 4th edition - Lessons for Canada's Life Sciences Industry

For the fourth year in a row, Montréal InVivo and TO Health!, in collaboration with Life Sciences BC, will hold an allied event for SMEs, entrepreneurs and life science sector stakeholders, on the week of the 2019 BIO International Convention in Philadelphia.

This event will bring together a panel of experts to address new trends and approaches in venture capital financing and biotech/health tech investment strategies. This year’s discussion will focus on trends in supporting growth and development of companies in life sciences through Corporate Venture Funds and other venture models.

Opening remarks by :

Pierre Fitzgibbon, Minister of Economy and Innovation, Quebec
Todd Smith, Minister of Economic Development, Job Creation and Trade, and Government House Leader, Ontario

Panelists:

Diana Bernstein, Senior Associate, MRL Ventures
Barbara Dalton, Senior Managing Partner, Pfizer Ventures and Vice President, Worldwide Business Development, Pfizer Inc.
Alicia Irurzun-Lafitte, Partner, UCB Ventures
James Kasuboski, Senior Director, Boehringer Ingelheim Venture Fund USA
Frederic D. Sweeney, Chief Business Officer at Northern Biologics, EIR at Versant Ventures

Panel Moderator:

Cedric Bisson, Partner, Teralys Capital



Date: Monday June 3rd, 2019

Time: 1:00 p.m. – 2:15 p.m.

Location: Le Méridien Philadelphia, Abele Library

*Doors open at 12:45 p.m

The room will be available until 2:45 p.m. for networking


As space is limited we invite you to register now. Maximum tickets per person is 2.

Hope to see you there!


Event sponsored by Fasken, GSK and National Bank


Organisé par

Montréal InVivo désigne la grappe des sciences de la vie et des technologies de la santé (SVTS) du Montréal métropolitain. Cet ensemble est constitué de près de 600 organisations, dont plus de 150 centres de recherche, 80 filiales d'entreprises de classe mondiale et plus de 40 000 personnes œuvrant dans le secteur. Cette grappe créatrice de grandes idées comprend quatre universités et se classe première au Canada pour le nombre de centres de recherche.

Montréal InVivo est un organisme sans but lucratif de développement économique voué à la création de la richesse. Ses activités sont supportées par un financement provenant du ministère de l'Économie, de la Science et de l'Innovation (MESI), du Secrétariat à la région métropolitaine relevant du Ministère des Affaires municipales et de l'Occupation du territoire, de la Communauté métropolitaine de Montréal (CMM), de Développement économique Canada pour les régions du Québec (DEC) et des secteurs privés et institutionnels.

-----

Montréal InVivo refers to the life sciences and health technologies (LSHT) cluster of metropolitan Montreal. This group is made up of nearly 600 organizations, including more than 150 research centers, 80 subsidiaries of world-class companies and more than 40,000 people working in the sector. This big-idea cluster includes four universities and ranks first in Canada for the number of research centers.

Montréal InVivo is a non-profit economic development organization dedicated to the creation of wealth. Its activities are supported by funding from the Ministry of Economy, Science and Innovation (MESI), the Secretariat for the Metropolitan Region under the Ministry of Municipal Affairs and Land Occupancy, the Communauté Métropolitaine de Montréal (CMM), Canada Economic Development for Quebec Regions (CED) and the private and institutional sectors.

Fin des ventes